COVID-19 Impact on Nebulizers, Inhalers and Respirators for Asthma Treatment Market , Global Research Reports 2020-2021

1.2 Market Segmentation

1.3 Research Objectives

1.4 Research Methodology

1.4.1 Research Process

1.4.2 Data Triangulation

1.4.3 Research Approach

1.4.4 Base Year

1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

1.5.2 Covid-19 Impact: Commodity Prices Indices

1.5.3 Covid-19 Impact: Global Major Government Policy

1.6 The Covid-19 Impact on Nebulizers, Inhalers and Respirators for Asthma Treatment Industry

1.7 COVID-19 Impact: Nebulizers, Inhalers and Respirators for Asthma Treatment Market Trends

2 Global Nebulizers, Inhalers and Respirators for Asthma Treatment Quarterly Market Size Analysis

2.1 Nebulizers, Inhalers and Respirators for Asthma Treatment Business Impact Assessment - COVID-19

2.1.1 Global Nebulizers, Inhalers and Respirators for Asthma Treatment Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.1.2 Global Nebulizers, Inhalers and Respirators for Asthma Treatment Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.2 Global Nebulizers, Inhalers and Respirators for Asthma Treatment Quarterly Market Size 2020-2021

2.3 COVID-19-Driven Market Dynamics and Factor Analysis

2.3.1 Drivers

2.3.2 Restraints

2.3.3 Opportunities

2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020

3.1 Global Nebulizers, Inhalers and Respirators for Asthma Treatment Quarterly Market Size by Manufacturers, 2019 VS 2020

3.2 Global Nebulizers, Inhalers and Respirators for Asthma Treatment Factory Price by Manufacturers

3.3 Location of Key Manufacturers Nebulizers, Inhalers and Respirators for Asthma Treatment Manufacturing Factories and Area Served

3.4 Date of Key Manufacturers Enter into Nebulizers, Inhalers and Respirators for Asthma Treatment Market

3.5 Key Manufacturers Nebulizers, Inhalers and Respirators for Asthma Treatment Product Offered

3.6 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Nebulizers, Inhalers and Respirators for Asthma Treatment Segments, By Type

4.1 Introduction

1.4.1 Nebulizers

1.4.2 Inhalers

1.4.3 Respirators

4.2 By Type, Global Nebulizers, Inhalers and Respirators for Asthma Treatment Market Size, 2019-2021

4.2.1 By Type, Global Nebulizers, Inhalers and Respirators for Asthma Treatment Market Size by Type, 2020-2021

4.2.2 By Type, Global Nebulizers, Inhalers and Respirators for Asthma Treatment Price, 2020-2021

5 Impact of Covid-19 on Nebulizers, Inhalers and Respirators for Asthma Treatment Segments, By Application

5.1 Overview

5.5.1 Hospitals

5.5.2 Clinics

5.5.3 Home Care

5.5.4 Others

5.2 By Application, Global Nebulizers, Inhalers and Respirators for Asthma Treatment Market Size, 2019-2021

5.2.1 By Application, Global Nebulizers, Inhalers and Respirators for Asthma Treatment Market Size by Application, 2019-2021

5.2.2 By Application, Global Nebulizers, Inhalers and Respirators for Asthma Treatment Price, 2020-2021

6 Geographic Analysis

6.1 Introduction

6.2 North America

6.2.1 Macroeconomic Indicators of US

6.2.2 US

6.2.3 Canada

6.3 Europe

6.3.1 Macroeconomic Indicators of Europe

6.3.2 Germany

6.3.3 France

6.3.4 UK

6.3.5 Italy

6.4 Asia-Pacific

6.4.1 Macroeconomic Indicators of Asia-Pacific

6.4.2 China

6.4.3 Japan

6.4.4 South Korea

6.4.5 India

6.4.6 ASEAN

6.5 Rest of World

6.5.1 Latin America

6.5.2 Middle East and Africa

7 Company Profiles

7.1 PARI GmbH

7.1.1 PARI GmbH Business Overview

7.1.2 PARI GmbH Nebulizers, Inhalers and Respirators for Asthma Treatment Quarterly Production and Revenue, 2020

7.1.3 PARI GmbH Nebulizers, Inhalers and Respirators for Asthma Treatment Product Introduction

7.1.4 PARI GmbH Response to COVID-19 and Related Developments

7.2 3M Healthcare

7.2.1 3M Healthcare Business Overview

7.2.2 3M Healthcare Nebulizers, Inhalers and Respirators for Asthma Treatment Quarterly Production and Revenue, 2020

7.2.3 3M Healthcare Nebulizers, Inhalers and Respirators for Asthma Treatment Product Introduction

7.2.4 3M Healthcare Response to COVID-19 and Related Developments

7.3 Astrazeneca

7.3.1 Astrazeneca Business Overview

7.3.2 Astrazeneca Nebulizers, Inhalers and Respirators for Asthma Treatment Quarterly Production and Revenue, 2020

7.3.3 Astrazeneca Nebulizers, Inhalers and Respirators for Asthma Treatment Product Introduction

7.3.4 Astrazeneca Response to COVID-19 and Related Developments

7.4 GlaxoSmithKline

7.4.1 GlaxoSmithKline Business Overview

7.4.2 GlaxoSmithKline Nebulizers, Inhalers and Respirators for Asthma Treatment Quarterly Production and Revenue, 2020

7.4.3 GlaxoSmithKline Nebulizers, Inhalers and Respirators for Asthma Treatment Product Introduction

7.4.4 GlaxoSmithKline Response to COVID-19 and Related Developments

7.5 Drive DeVilbiss Healthcare

7.5.1 Drive DeVilbiss Healthcare Business Overview

7.5.2 Drive DeVilbiss Healthcare Nebulizers, Inhalers and Respirators for Asthma Treatment Quarterly Production and Revenue, 2020

7.5.3 Drive DeVilbiss Healthcare Nebulizers, Inhalers and Respirators for Asthma Treatment Product Introduction

7.5.4 Drive DeVilbiss Healthcare Response to COVID-19 and Related Developments

7.6 Philips Respironics

7.6.1 Philips Respironics Business Overview

7.6.2 Philips Respironics Nebulizers, Inhalers and Respirators for Asthma Treatment Quarterly Production and Revenue, 2020

7.6.3 Philips Respironics Nebulizers, Inhalers and Respirators for Asthma Treatment Product Introduction

7.6.4 Philips Respironics Response to COVID-19 and Related Developments

7.7 Omron

7.7.1 Omron Business Overview

7.7.2 Omron Nebulizers, Inhalers and Respirators for Asthma Treatment Quarterly Production and Revenue, 2020

7.7.3 Omron Nebulizers, Inhalers and Respirators for Asthma Treatment Product Introduction

7.7.4 Omron Response to COVID-19 and Related Developments

7.8 Invacare

7.8.1 Invacare Business Overview

7.8.2 Invacare Nebulizers, Inhalers and Respirators for Asthma Treatment Quarterly Production and Revenue, 2020

7.8.3 Invacare Nebulizers, Inhalers and Respirators for Asthma Treatment Product Introduction

7.8.4 Invacare Response to COVID-19 and Related Developments

7.9 Boehringer Ingelheim

7.9.1 Boehringer Ingelheim Business Overview

7.9.2 Boehringer Ingelheim Nebulizers, Inhalers and Respirators for Asthma Treatment Quarterly Production and Revenue, 2020

7.9.3 Boehringer Ingelheim Nebulizers, Inhalers and Respirators for Asthma Treatment Product Introduction

7.9.4 Boehringer Ingelheim Response to COVID-19 and Related Developments

7.10 Drager

7.10.1 Drager Business Overview

7.10.2 Drager Nebulizers, Inhalers and Respirators for Asthma Treatment Quarterly Production and Revenue, 2020

7.10.3 Drager Nebulizers, Inhalers and Respirators for Asthma Treatment Product Introduction

7.10.4 Drager Response to COVID-19 and Related Developments

7.11 Yuwell

7.11.1 Yuwell Business Overview

7.11.2 Yuwell Nebulizers, Inhalers and Respirators for Asthma Treatment Quarterly Production and Revenue, 2020

7.11.3 Yuwell Nebulizers, Inhalers and Respirators for Asthma Treatment Product Introduction

7.11.4 Yuwell Response to COVID-19 and Related Developments

7.12 GF Health Products

7.12.1 GF Health Products Business Overview

7.12.2 GF Health Products Nebulizers, Inhalers and Respirators for Asthma Treatment Quarterly Production and Revenue, 2020

7.12.3 GF Health Products Nebulizers, Inhalers and Respirators for Asthma Treatment Product Introduction

7.12.4 GF Health Products Response to COVID-19 and Related Developments

8 Supply Chain and Sales Channels Analysis

8.1 Nebulizers, Inhalers and Respirators for Asthma Treatment Supply Chain Analysis

8.1.1 Nebulizers, Inhalers and Respirators for Asthma Treatment Supply Chain Analysis

8.1.2 Covid-19 Impact on Nebulizers, Inhalers and Respirators for Asthma Treatment Supply Chain

8.2 Distribution Channels Analysis

8.2.1 Nebulizers, Inhalers and Respirators for Asthma Treatment Distribution Channels

8.2.2 Covid-19 Impact on Nebulizers, Inhalers and Respirators for Asthma Treatment Distribution Channels

8.2.3 Nebulizers, Inhalers and Respirators for Asthma Treatment Distributors

8.3 Nebulizers, Inhalers and Respirators for Asthma Treatment Customers

9 Key Findings

10 Appendix

10.1 About Us

10.2 Disclaimer

Table 1. Overview of the World Economic Outlook Projections

Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 7. Covid-19 Impact: Global Major Government Policy

Table 8. The Covid-19 Impact on Nebulizers, Inhalers and Respirators for Asthma Treatment Assessment

Table 9. COVID-19 Impact: Nebulizers, Inhalers and Respirators for Asthma Treatment Market Trends

Table 10. COVID-19 Impact Global Nebulizers, Inhalers and Respirators for Asthma Treatment Market Size

Table 11. Global Nebulizers, Inhalers and Respirators for Asthma Treatment Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)

Table 12. Global Nebulizers, Inhalers and Respirators for Asthma Treatment Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)

Table 13. Global Nebulizers, Inhalers and Respirators for Asthma Treatment Quarterly Market Size, 2020 (US$ Million) & (K Units)

Table 14. Global Nebulizers, Inhalers and Respirators for Asthma Treatment Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)

Table 15. Global Nebulizers, Inhalers and Respirators for Asthma Treatment Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)

Table 16. Global Nebulizers, Inhalers and Respirators for Asthma Treatment Market Growth Drivers

Table 17. Global Nebulizers, Inhalers and Respirators for Asthma Treatment Market Restraints

Table 18. Global Nebulizers, Inhalers and Respirators for Asthma Treatment Market Opportunities

Table 19. Global Nebulizers, Inhalers and Respirators for Asthma Treatment Market Challenges

Table 20. Key Manufacturers Nebulizers, Inhalers and Respirators for Asthma Treatment Quarterly Revenue, 2019 VS 2020 (US$ Million)

Table 21. Top Manufacturers, Nebulizers, Inhalers and Respirators for Asthma Treatment Market Size, 2019 (K Units) & (US$ Million)

Table 22. Nebulizers, Inhalers and Respirators for Asthma Treatment Factory Price by Manufacturers 2020 (USD/Unit)

Table 23. Location of Key Manufacturers Nebulizers, Inhalers and Respirators for Asthma Treatment Manufacturing Plants

Table 24. Key Manufacturers Nebulizers, Inhalers and Respirators for Asthma Treatment Market Served

Table 25. Date of Key Manufacturers Enter into Nebulizers, Inhalers and Respirators for Asthma Treatment Market

Table 26. Key Manufacturers Nebulizers, Inhalers and Respirators for Asthma Treatment Product Type

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Nebulizers, Inhalers and Respirators for Asthma Treatment Market Size by Type, 2020, (US$ Million)

Table 29. Global Nebulizers, Inhalers and Respirators for Asthma Treatment Market Size by Type, 2020 (K Units)

Table 30. Global Nebulizers, Inhalers and Respirators for Asthma Treatment Price: by Type, 2020-2021 (USD/Unit)

Table 31. Global Nebulizers, Inhalers and Respirators for Asthma Treatment Market Size by Application: 2020-2021 (US$ Million)

Table 32. Global Nebulizers, Inhalers and Respirators for Asthma Treatment Market Size by Application, 2020-2021 (K Units)

Table 33. Global Nebulizers, Inhalers and Respirators for Asthma Treatment Price: by Application, 2020-2021 (USD/Unit)

Table 34. Global Nebulizers, Inhalers and Respirators for Asthma Treatment Market Size by Region, 2019-2021 (US$ Million)

Table 35. Global Nebulizers, Inhalers and Respirators for Asthma Treatment Market Size by Region, 2019-2021 (K Units)

Table 36. By Country, North America Nebulizers, Inhalers and Respirators for Asthma Treatment Market Size, 2019-2021 (US$ Million)

Table 37. By Country, North America Nebulizers, Inhalers and Respirators for Asthma Treatment Market Size, 2019-2021 (K Units)

Table 38. US Nebulizers, Inhalers and Respirators for Asthma Treatment Market Size, 2019-2021 (US$ Million) & (K Units)

Table 39. Canada Nebulizers, Inhalers and Respirators for Asthma Treatment Market Size, 2019-2021 (US$ Million) & (K Units)

Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)

Table 41. By Country, Europe Nebulizers, Inhalers and Respirators for Asthma Treatment Market Size, 2019-2021 (US$ Million)

Table 42. By Country, Europe Nebulizers, Inhalers and Respirators for Asthma Treatment Market Size, 2019-2021 (K Units)

Table 43. Germany Nebulizers, Inhalers and Respirators for Asthma Treatment Market Size, 2019-2021 (US$ Million) & (K Units)

Table 44. France Nebulizers, Inhalers and Respirators for Asthma Treatment Market Size, 2019-2021 (US$ Million) & (K Units)

Table 45. UK Nebulizers, Inhalers and Respirators for Asthma Treatment Market Size, 2019-2021 (US$ Million) & (K Units)

Table 46. Italy Nebulizers, Inhalers and Respirators for Asthma Treatment Market Size, 2019-2021 (US$ Million) & (K Units)

Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)

Table 48. By Region, Asia-Pacific Nebulizers, Inhalers and Respirators for Asthma Treatment Market Size, 2019-2021 (US$ Million)

Table 49. By Region, Asia-Pacific Nebulizers, Inhalers and Respirators for Asthma Treatment Market Size, 2019-2021 (K Units)

Table 50. China Nebulizers, Inhalers and Respirators for Asthma Treatment Market Size, 2019-2021 (US$ Million) & (K Units)

Table 51. Japan Nebulizers, Inhalers and Respirators for Asthma Treatment Market Size, 2019-2021 (US$ Million) & (K Units)

Table 52. South Korea Nebulizers, Inhalers and Respirators for Asthma Treatment Market Size, 2019-2021 (US$ Million) & (K Units)

Table 53. India Nebulizers, Inhalers and Respirators for Asthma Treatment Market Size, 2019-2021 (US$ Million) & (K Units)

Table 54. ASEAN Nebulizers, Inhalers and Respirators for Asthma Treatment Market Size, 2019-2021 (US$ Million) & (K Units)

Table 55. Latin America Nebulizers, Inhalers and Respirators for Asthma Treatment Market Size, 2019-2021 (US$ Million) & (K Units)

Table 56. Middle East and Africa Nebulizers, Inhalers and Respirators for Asthma Treatment Market Size, 2019-2021 (US$ Million) & (K Units)

Table 57. PARI GmbH Business Overview

Table 58. PARI GmbH Nebulizers, Inhalers and Respirators for Asthma Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 59. PARI GmbH Nebulizers, Inhalers and Respirators for Asthma Treatment Product

Table 60. PARI GmbH Response to COVID-19 and Related Developments

Table 61. 3M Healthcare Business Overview

Table 62. 3M Healthcare Nebulizers, Inhalers and Respirators for Asthma Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 63. 3M Healthcare Nebulizers, Inhalers and Respirators for Asthma Treatment Product

Table 64. 3M Healthcare Response to COVID-19 and Related Developments

Table 65. Astrazeneca Business Overview

Table 66. Astrazeneca Nebulizers, Inhalers and Respirators for Asthma Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 67. Astrazeneca Nebulizers, Inhalers and Respirators for Asthma Treatment Product

Table 68. Astrazeneca Response to COVID-19 and Related Developments

Table 69. GlaxoSmithKline Business Overview

Table 70. GlaxoSmithKline Nebulizers, Inhalers and Respirators for Asthma Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 71. GlaxoSmithKline Nebulizers, Inhalers and Respirators for Asthma Treatment Product

Table 72. GlaxoSmithKline Response to COVID-19 and Related Developments

Table 73. Drive DeVilbiss Healthcare Business Overview

Table 74. Drive DeVilbiss Healthcare Nebulizers, Inhalers and Respirators for Asthma Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 75. Drive DeVilbiss Healthcare Nebulizers, Inhalers and Respirators for Asthma Treatment Product

Table 76. Drive DeVilbiss Healthcare Response to COVID-19 and Related Developments

Table 77. Philips Respironics Business Overview

Table 78. Philips Respironics Nebulizers, Inhalers and Respirators for Asthma Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 79. Philips Respironics Nebulizers, Inhalers and Respirators for Asthma Treatment Product

Table 80. Philips Respironics Response to COVID-19 and Related Developments

Table 81. Omron Business Overview

Table 82. Omron Nebulizers, Inhalers and Respirators for Asthma Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 83. Omron Nebulizers, Inhalers and Respirators for Asthma Treatment Product

Table 84. Omron Response to COVID-19 and Related Developments

Table 85. Invacare Business Overview

Table 86. Invacare Nebulizers, Inhalers and Respirators for Asthma Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 87. Invacare Nebulizers, Inhalers and Respirators for Asthma Treatment Product

Table 88. Invacare Response to COVID-19 and Related Developments

Table 89. Boehringer Ingelheim Business Overview

Table 90. Boehringer Ingelheim Nebulizers, Inhalers and Respirators for Asthma Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 91. Boehringer Ingelheim Nebulizers, Inhalers and Respirators for Asthma Treatment Product

Table 92. Boehringer Ingelheim Response to COVID-19 and Related Developments

Table 93. Drager Business Overview

Table 94. Drager Nebulizers, Inhalers and Respirators for Asthma Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 95. Drager Nebulizers, Inhalers and Respirators for Asthma Treatment Product

Table 96. Drager Response to COVID-19 and Related Developments

Table 97. Yuwell Business Overview

Table 98. Yuwell Nebulizers, Inhalers and Respirators for Asthma Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 99. Yuwell Nebulizers, Inhalers and Respirators for Asthma Treatment Product

Table 100. Yuwell Response to COVID-19 and Related Developments

Table 101. GF Health Products Business Overview

Table 102. GF Health Products Nebulizers, Inhalers and Respirators for Asthma Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 103. GF Health Products Nebulizers, Inhalers and Respirators for Asthma Treatment Product

Table 104. GF Health Products Response to COVID-19 and Related Developments

Table 105. Nebulizers, Inhalers and Respirators for Asthma Treatment Distributors List

Table 106. Nebulizers, Inhalers and Respirators for Asthma Treatment Customers List

Table 107. Covid-19 Impact on Nebulizers, Inhalers and Respirators for Asthma Treatment Customers

List of Figures

Figure 1. Nebulizers, Inhalers and Respirators for Asthma Treatment Product Picture

Figure 2. Nebulizers, Inhalers and Respirators for Asthma Treatment Market Segmentation

Figure 3. Research Objectives

Figure 4. Research Process

Figure 5. Data Triangulation

Figure 6. Research Approach

Figure 7. Commodity Prices-Metals Price Indices

Figure 8. Commodity Prices- Precious Metal Price Indices

Figure 9. Commodity Prices- Agricultural Raw Material Price Indices

Figure 10. Commodity Prices- Food and Beverage Price Indices

Figure 11. Commodity Prices- Fertilizer Price Indices

Figure 12. Commodity Prices- Energy Price Indices

Figure 13. G20+: Economic Policy Responses to COVID-19

Figure 14. Global Nebulizers, Inhalers and Respirators for Asthma Treatment Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)

Figure 15. Global Nebulizers, Inhalers and Respirators for Asthma Treatment Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)

Figure 16. Global Nebulizers, Inhalers and Respirators for Asthma Treatment Market Size, Quarterly Growth, 2020-2021 (%)

Figure 17. Global Nebulizers, Inhalers and Respirators for Asthma Treatment Market Size, Market Share by Type, 2019 VS 2020 (%)

Figure 18. Global Nebulizers, Inhalers and Respirators for Asthma Treatment Market Size, Market Share by Application, 2019 VS 2020 (%)

Figure 19. Global Nebulizers, Inhalers and Respirators for Asthma Treatment Market Size Market Share by Region, 2019 VS 2020 (%)

Figure 20. United States Composite PMI and GDP

Figure 21. Eurozone Composite PMI and GDP

Figure 22. Eurozone Core v. Periphery PMI Output Indices

Figure 23. Core v. Periphery PMI Employment Indices

Figure 24. UK Composite PMI and GDP

Figure 25. Caixin China Composite Output Index

Figure 26. Caixin China General Services Business Activity Index

Figure 27. Japan Composite Output Index

Figure 28. South Korea Manufacturing PMI

Figure 29. India Composite Output Index

Figure 30. ASEAN Manufacturing PMI

Figure 31. By Region, Asia-Pacific Nebulizers, Inhalers and Respirators for Asthma Treatment Market Size Market Share, 2019-2021